Gloria Dalla Costa, M.Sc.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Sclerosis | 22 | 2023 | 3079 | 3.050 |
Why?
|
Demyelinating Diseases | 7 | 2021 | 354 | 2.070 |
Why?
|
Neurofilament Proteins | 5 | 2021 | 318 | 1.470 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 2 | 2019 | 134 | 1.250 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 5 | 2020 | 518 | 1.210 |
Why?
|
Disabled Persons | 2 | 2023 | 1214 | 0.830 |
Why?
|
Infant Formula | 1 | 2019 | 199 | 0.600 |
Why?
|
Oligoclonal Bands | 2 | 2021 | 16 | 0.600 |
Why?
|
Intermediate Filaments | 3 | 2020 | 175 | 0.500 |
Why?
|
Immunologic Factors | 3 | 2019 | 1580 | 0.490 |
Why?
|
Facial Hemiatrophy | 1 | 2013 | 22 | 0.450 |
Why?
|
Myeloid Cells | 1 | 2017 | 808 | 0.430 |
Why?
|
Facial Pain | 1 | 2013 | 127 | 0.410 |
Why?
|
Professional Role | 1 | 2014 | 306 | 0.390 |
Why?
|
Walking | 4 | 2023 | 1182 | 0.390 |
Why?
|
Cesarean Section | 1 | 2019 | 1365 | 0.370 |
Why?
|
Neurology | 2 | 2018 | 764 | 0.360 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3134 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.260 |
Why?
|
Europe | 2 | 2020 | 3336 | 0.220 |
Why?
|
Clothing | 1 | 2020 | 95 | 0.180 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 2 | 2020 | 236 | 0.180 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2019 | 82 | 0.170 |
Why?
|
Wireless Technology | 1 | 2020 | 100 | 0.170 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2018 | 38 | 0.170 |
Why?
|
Optic Nerve | 1 | 2021 | 554 | 0.150 |
Why?
|
Guillain-Barre Syndrome | 1 | 2019 | 121 | 0.150 |
Why?
|
Search Engine | 1 | 2019 | 144 | 0.150 |
Why?
|
Social Isolation | 1 | 2020 | 367 | 0.150 |
Why?
|
Immunosuppressive Agents | 3 | 2020 | 4152 | 0.150 |
Why?
|
Adult | 17 | 2023 | 213889 | 0.150 |
Why?
|
Humans | 35 | 2023 | 743811 | 0.140 |
Why?
|
Disability Evaluation | 1 | 2023 | 1828 | 0.140 |
Why?
|
Postural Balance | 1 | 2020 | 621 | 0.130 |
Why?
|
Superoxide Dismutase | 1 | 2017 | 595 | 0.130 |
Why?
|
Cell Polarity | 1 | 2017 | 645 | 0.120 |
Why?
|
Female | 20 | 2023 | 380020 | 0.120 |
Why?
|
Middle Aged | 13 | 2023 | 213241 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1060 | 0.110 |
Why?
|
Prognosis | 3 | 2020 | 29052 | 0.110 |
Why?
|
Seasons | 1 | 2019 | 1493 | 0.110 |
Why?
|
Motor Cortex | 1 | 2020 | 986 | 0.110 |
Why?
|
Age of Onset | 1 | 2019 | 3268 | 0.100 |
Why?
|
Interleukin-1beta | 1 | 2017 | 973 | 0.100 |
Why?
|
Disease Progression | 5 | 2021 | 13273 | 0.100 |
Why?
|
Male | 15 | 2023 | 349776 | 0.100 |
Why?
|
Immunomodulation | 1 | 2015 | 541 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 1423 | 0.100 |
Why?
|
Data Collection | 1 | 2020 | 3339 | 0.100 |
Why?
|
Breast Feeding | 1 | 2019 | 1338 | 0.090 |
Why?
|
Young Adult | 6 | 2021 | 56392 | 0.090 |
Why?
|
Fructose | 1 | 2012 | 287 | 0.090 |
Why?
|
Migraine with Aura | 1 | 2012 | 203 | 0.090 |
Why?
|
Migraine Disorders | 2 | 2013 | 1620 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1256 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2883 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1619 | 0.090 |
Why?
|
Cohort Studies | 4 | 2019 | 40545 | 0.080 |
Why?
|
World Health Organization | 1 | 2014 | 1317 | 0.080 |
Why?
|
Patients | 1 | 2014 | 899 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9440 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39001 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2015 | 6356 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3769 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4477 | 0.070 |
Why?
|
Italy | 2 | 2020 | 829 | 0.070 |
Why?
|
Vitamins | 1 | 2013 | 1622 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 5983 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10629 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13980 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1342 | 0.060 |
Why?
|
Brain | 4 | 2021 | 26345 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15211 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2874 | 0.060 |
Why?
|
Learning | 1 | 2012 | 1710 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 9944 | 0.050 |
Why?
|
Social Conditions | 1 | 2022 | 126 | 0.050 |
Why?
|
Patient Selection | 1 | 2014 | 4210 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3229 | 0.050 |
Why?
|
Communication | 1 | 2014 | 3748 | 0.050 |
Why?
|
Acceleration | 1 | 2020 | 183 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 21733 | 0.040 |
Why?
|
Pregnancy | 2 | 2019 | 29140 | 0.040 |
Why?
|
Vitamin D | 1 | 2013 | 3222 | 0.040 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2019 | 91 | 0.040 |
Why?
|
Receptors, CCR6 | 1 | 2019 | 81 | 0.040 |
Why?
|
Spain | 1 | 2020 | 464 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 25609 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 35409 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 140 | 0.040 |
Why?
|
Pyramidal Tracts | 1 | 2020 | 255 | 0.040 |
Why?
|
Adolescent | 5 | 2021 | 85729 | 0.040 |
Why?
|
Denmark | 1 | 2020 | 738 | 0.040 |
Why?
|
Evoked Potentials, Motor | 1 | 2020 | 454 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2014 | 4467 | 0.040 |
Why?
|
Infant | 1 | 2019 | 35122 | 0.040 |
Why?
|
Epilepsy | 1 | 2012 | 3284 | 0.040 |
Why?
|
Pain | 1 | 2012 | 4987 | 0.040 |
Why?
|
Visual Pathways | 1 | 2021 | 558 | 0.040 |
Why?
|
Interferon-beta | 1 | 2018 | 324 | 0.040 |
Why?
|
Retrospective Studies | 4 | 2021 | 77410 | 0.030 |
Why?
|
Drug Substitution | 1 | 2018 | 281 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40038 | 0.030 |
Why?
|
Netherlands | 1 | 2020 | 2170 | 0.030 |
Why?
|
Gadolinium | 1 | 2021 | 950 | 0.030 |
Why?
|
Electromyography | 1 | 2020 | 1378 | 0.030 |
Why?
|
Hand | 1 | 2020 | 884 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1836 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1738 | 0.030 |
Why?
|
Lymphocytes | 1 | 2021 | 2615 | 0.030 |
Why?
|
Temperature | 1 | 2019 | 2202 | 0.030 |
Why?
|
Pain, Intractable | 1 | 2013 | 130 | 0.030 |
Why?
|
Accidental Falls | 1 | 2020 | 1062 | 0.030 |
Why?
|
Risk Factors | 2 | 2015 | 72252 | 0.020 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2020 | 1433 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2014 | 63042 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2657 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3718 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5301 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7793 | 0.020 |
Why?
|
Axons | 1 | 2015 | 1685 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4406 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3921 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12718 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8337 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 12788 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15067 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9139 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6237 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57744 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15526 | 0.010 |
Why?
|
Physicians | 1 | 2013 | 4569 | 0.010 |
Why?
|
United States | 1 | 2019 | 69859 | 0.010 |
Why?
|
Aged | 1 | 2020 | 163178 | 0.000 |
Why?
|